Pregnancy in patients with pulmonary hypertension: a systematic review and meta-analysis with meta-regression.

IF 1.9 3区 医学 Q3 RESPIRATORY SYSTEM
Journal of thoracic disease Pub Date : 2025-07-31 Epub Date: 2025-07-28 DOI:10.21037/jtd-2025-430
Mahmoud El Iskandarani, Reshma Golamari, Branco G M Bettinotti, Elias Akiki, Daniela Urina Jassir, Tarec K Elajami, Francine K Welty, Esteban Escolar, Christos G Mihos
{"title":"Pregnancy in patients with pulmonary hypertension: a systematic review and meta-analysis with meta-regression.","authors":"Mahmoud El Iskandarani, Reshma Golamari, Branco G M Bettinotti, Elias Akiki, Daniela Urina Jassir, Tarec K Elajami, Francine K Welty, Esteban Escolar, Christos G Mihos","doi":"10.21037/jtd-2025-430","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pregnancy in patients with significant pulmonary hypertension (PH) is a contraindication due to high maternal and fetal mortality. However, recent data shows that an increasing number of women with PH are successfully carrying pregnancies to term, likely because of advancements in multidisciplinary care and treatment. This systematic review and meta-analysis aims to evaluate recent outcomes and identify risk factors associated with morbidity and mortality in this high-risk group.</p><p><strong>Methods: </strong>An unrestricted search was conducted across MEDLINE, EMBASE, and Cochrane databases for studies on outcomes in pregnant patients with PH from inception until May 30, 2024. For one-group analyses, event rates and 95% confidence interval (CI) were calculated using a random-effects model. Meta-regression was performed with Comprehensive Meta-Analysis version 4, employing covariates in logistic regression models. For two-group comparisons, odd ratios (ORs) and 95% CIs were calculated using Review Manager version 5.4 utilizing a random-effects model.</p><p><strong>Results: </strong>Fifty-one studies involving 4,583 pregnant patients with PH were included. The maternal mortality rate was 7.6% (95% CI: 5.8-9.9%). Most deaths (93%) occurred in the postpartum period. Severe PH was associated with a significantly higher rate of maternal mortality compared to mild/moderate PH with OR 5.57 (95% CI: 3.12-9.94). Higher systolic pulmonary artery pressure (sPAP) was associated with a higher mortality rate with a regression coefficient of 0.96. Similarly, the presence of Eisenmenger syndrome (ES) was linked to a higher mortality rate with a regression coefficient of 1. Severe PH was also associated with higher rates of abortion (OR =3.64, 95% CI: 2.61-5.09), prematurity (OR =2.52, 95% CI: 1.66-3.81), and small gestational age (OR =3.96, 95% CI: 2.96-5.29) compared with mild/moderate PH.</p><p><strong>Conclusions: </strong>Although the outcomes of pregnant patients with PH continue to improve, severe PH continues to be associated with a high mortality rate, abortion rate, prematurity, and small gestational age. Our findings support the existing consensus against pregnancy in severe PH and emphasize the need for thorough, individualized discussions about risks for patients with mild/moderate PH.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"17 7","pages":"5108-5121"},"PeriodicalIF":1.9000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12340376/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thoracic disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jtd-2025-430","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/28 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Pregnancy in patients with significant pulmonary hypertension (PH) is a contraindication due to high maternal and fetal mortality. However, recent data shows that an increasing number of women with PH are successfully carrying pregnancies to term, likely because of advancements in multidisciplinary care and treatment. This systematic review and meta-analysis aims to evaluate recent outcomes and identify risk factors associated with morbidity and mortality in this high-risk group.

Methods: An unrestricted search was conducted across MEDLINE, EMBASE, and Cochrane databases for studies on outcomes in pregnant patients with PH from inception until May 30, 2024. For one-group analyses, event rates and 95% confidence interval (CI) were calculated using a random-effects model. Meta-regression was performed with Comprehensive Meta-Analysis version 4, employing covariates in logistic regression models. For two-group comparisons, odd ratios (ORs) and 95% CIs were calculated using Review Manager version 5.4 utilizing a random-effects model.

Results: Fifty-one studies involving 4,583 pregnant patients with PH were included. The maternal mortality rate was 7.6% (95% CI: 5.8-9.9%). Most deaths (93%) occurred in the postpartum period. Severe PH was associated with a significantly higher rate of maternal mortality compared to mild/moderate PH with OR 5.57 (95% CI: 3.12-9.94). Higher systolic pulmonary artery pressure (sPAP) was associated with a higher mortality rate with a regression coefficient of 0.96. Similarly, the presence of Eisenmenger syndrome (ES) was linked to a higher mortality rate with a regression coefficient of 1. Severe PH was also associated with higher rates of abortion (OR =3.64, 95% CI: 2.61-5.09), prematurity (OR =2.52, 95% CI: 1.66-3.81), and small gestational age (OR =3.96, 95% CI: 2.96-5.29) compared with mild/moderate PH.

Conclusions: Although the outcomes of pregnant patients with PH continue to improve, severe PH continues to be associated with a high mortality rate, abortion rate, prematurity, and small gestational age. Our findings support the existing consensus against pregnancy in severe PH and emphasize the need for thorough, individualized discussions about risks for patients with mild/moderate PH.

肺动脉高压患者妊娠:一项系统回顾和meta回归分析。
背景:严重肺动脉高压(PH)患者妊娠是一个禁忌症,因为产妇和胎儿死亡率高。然而,最近的数据显示,越来越多的PH妇女成功怀孕至足月,可能是因为多学科护理和治疗的进步。本系统综述和荟萃分析旨在评估这一高危人群的近期结果,并确定与发病率和死亡率相关的危险因素。方法:对MEDLINE、EMBASE和Cochrane数据库进行无限制检索,从研究开始到2024年5月30日,对妊娠PH患者的结局进行研究。对于单组分析,使用随机效应模型计算事件发生率和95%置信区间(CI)。采用综合荟萃分析版本4进行meta回归,采用逻辑回归模型中的协变量。对于两组比较,使用Review Manager version 5.4利用随机效应模型计算奇比(or)和95% ci。结果:纳入51项研究,涉及4583例妊娠PH患者。产妇死亡率为7.6%(95%置信区间:5.8-9.9%)。大多数死亡(93%)发生在产后。与轻度/中度PH相比,重度PH与显著更高的孕产妇死亡率相关,OR为5.57 (95% CI: 3.12-9.94)。较高的肺动脉收缩压(sPAP)与较高的死亡率相关,回归系数为0.96。同样,艾森门格综合征(ES)的存在与较高的死亡率相关,回归系数为1。与轻度/中度PH相比,重度PH还与更高的流产率(OR =3.64, 95% CI: 2.61-5.09)、早产率(OR =2.52, 95% CI: 1.66-3.81)和小胎龄(OR =3.96, 95% CI: 2.96-5.29)相关。结论:尽管妊娠PH患者的结局持续改善,但重度PH仍然与高死亡率、流产率、早产率和小胎龄相关。我们的研究结果支持现有的反对重度PH患者怀孕的共识,并强调需要对轻度/中度PH患者的风险进行彻底、个性化的讨论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of thoracic disease
Journal of thoracic disease RESPIRATORY SYSTEM-
CiteScore
4.60
自引率
4.00%
发文量
254
期刊介绍: The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信